exRNAdisease

Entry Detail

---



General Information

Database ID: exR0275721 RNA Name: hsa-miR-520b-3p RNA Type: miRNA Chromosome: chr19 Starnd: + Coordinate: Start Site(bp): 53701267 End Site(bp): 53701287 External Links: hsa-miR-520b-3p

Disease Information

Disease Name: Advanced Adenoma Disease Category: Cancers MeSH ID: D000236 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Adenoma//Adenomas//Adenoma, Follicular//Adenomas, Follicular//Follicular Adenoma//Follicular Adenomas//Adenoma, Trabecular//Adenomas, Trabecular//Trabecular Adenoma//Trabecular Adenomas//Adenoma, Monomorphic//Adenomas, Monomorphic//Monomorphic Adenoma//Monomorphic Adenomas//Adenoma, Papillary//Adenomas, Papillary//Papillary Adenoma//Papillary Adenomas//Adenoma, Basal Cell//Adenomas, Basal Cell//Basal Cell Adenoma//Basal Cell Adenomas//Adenoma, Microcystic//Adenomas, Microcystic//Microcystic Adenoma//Microcystic Adenomas

Expression Detail

GEO ID: GSE25609 Description: Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening Experimental Design: Cancer vs Control Case Disease Type: Advanced Adenoma Case Disease SubType: NA Case Sample: Advanced Adenoma Post surgery Control Sample: Control Number of Case: 20 Number of Control: 20 Number of Samples: 40

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand TNS1 chr2 217799588 218033982 - CLCN6 chr1 11806096 11848079 + SIRPA chr20 1894167 1940592 + CELF2 chr10 10798397 11336675 + MBP chr18 76978827 77133683 - PLAGL2 chr20 32192504 32207743 - APP chr21 25880550 26171128 - KLHL28 chr14 44924319 45042322 - SEC16A chr9 136440096 136483759 - CCDC93 chr2 117915478 118014133 - MAGI3 chr1 113390515 113685923 + PTP4A1 chr6 63521746 63583436 + SYAP1 chrX 16719612 16765340 + SEMA3C chr7 80742538 80922359 - ADAR chr1 154582057 154628013 - CUL1 chr7 148697914 148801110 + CHD9 chr16 53055033 53329150 + TRIB1 chr8 125430358 125438403 + SLC16A14 chr2 230034982 230068993 - IFNAR1 chr21 33324429 33359864 + WDR82 chr3 52254434 52288020 - RUNDC1 chr17 42980565 42993690 + NPAS2 chr2 100820139 100996829 + JPT1 chr17 75135248 75168281 - LONP2 chr16 48244300 48363122 + OCRL chrX 129539849 129592561 + ZFAND4 chr10 45615500 45672780 - PHC3 chr3 170086732 170181749 - ATXN1 chr6 16299112 16761491 - FAM177A1 chr14 35044907 35113130 + miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AL049840.4 chr14 103694516 103695050 - ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - FGD5-AS1 chr3 14920347 14948424 - MIR17HG chr13 91347820 91354579 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE25609 Sample Source: Blood Source Fraction: Plasma Platform: GPL8179 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 826 Sample treatment protocol: Briefly, samples were centrifuged at 1,600×g for 10 min at 4 ºC to spin down blood cells, and plasma was transferred into new tubes, followed by further centrifugation at 16,000×g for 10 minutes at 4ºC to completely remove cellular components. RNA Extract protocol: NA RNA library preparation protocol: Biotinylated cDNA were prepared with the Illumina® TotalPrep™ RNA Amplification Kit (Ambion).

Reference

PMID: 23267864 Title: Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Author: Gir¨¢ldez MD, Lozano JJ, Ram¨ªrez G, Hijona E, Bujanda L, Castells A, Gironella M Journal: Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3. Description: We investigated whether plasma levels of miRNA can differentiate patients with CRC from healthy individuals. We also investigated whether plasma samples from patients with premalignant neoplastic lesions, such as advanced adenomas (AAs), also had a different expression pattern of miRNAs.